French Glendon E. III's Form 4 filing
Pulmonx Corp (LUNG) · filed Jun 3, 2022
- Accession no.
- 0001209191-22-034297
- Filed
- Jun 3, 2022
- Trade date
- Jun 1, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $45.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| French Glendon E. IIICIK 0001805624 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2022 | Common Stock | SSaleDisposed | −998 | $18.05 | −$18,013.9 | 1,106,519 | Direct | |
| Jun 1, 2022 | Common Stock | SSaleDisposed | −1,525 | $18.05 | −$27,526.25 | 1,104,994 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.